SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-23-006169
Filing Date
2023-04-28
Accepted
2023-04-28 16:06:25
Documents
137
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 bp42123020f.htm   iXBRL 20-F 3257670
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 607929
3 EXHIBIT 2.1 ex2_1.htm EX-2.1 187863
4 EXHIBIT 8.1 ex8_1.htm EX-8.1 8413
5 EXHIBIT 12.1 ex12_1.htm EX-12.1 9122
6 EXHIBIT 13.1 ex13_1.htm EX-13.1 5039
7 EXHIBIT 15.1 ex15_1.htm EX-15.1 5834
13 GRAPHIC mazars_medlogo.jpg GRAPHIC 9194
14 GRAPHIC pipelineandplatform.jpg GRAPHIC 30164
15 GRAPHIC brownrudnick_logo.jpg GRAPHIC 6476
  Complete submission text file 0001214659-23-006169.txt   13911372

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mtp-20221231.xsd EX-101.SCH 107299
9 XBRL CALCULATION FILE mtp-20221231_cal.xml EX-101.CAL 80977
10 XBRL DEFINITION FILE mtp-20221231_def.xml EX-101.DEF 261687
11 XBRL LABEL FILE mtp-20221231_lab.xml EX-101.LAB 487708
12 XBRL PRESENTATION FILE mtp-20221231_pre.xml EX-101.PRE 439123
131 EXTRACTED XBRL INSTANCE DOCUMENT bp42123020f_htm.xml XML 3010496
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37652 | Film No.: 23865943
SIC: 2834 Pharmaceutical Preparations